Viewing Study NCT04823702


Ignite Creation Date: 2025-12-25 @ 3:57 AM
Ignite Modification Date: 2025-12-26 @ 2:49 AM
Study NCT ID: NCT04823702
Status: COMPLETED
Last Update Posted: 2022-01-19
First Post: 2021-03-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study of Aldafermin (NGM282) in Participants With Impaired Hepatic Function
Sponsor: NGM Biopharmaceuticals, Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module